Cryptogenic organizing pneumonia after withdrawal of systemic corticosteroids for chronic eosinophilic pneumonia and severe asthma under benralizumab treatment
Copyright © 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved..
A 79-year-old woman with severe asthma developed chronic eosinophilic pneumonia (CEP). After CEP resolved with oral prednisolone at 30 mg/day, prednisolone was tapered and discontinued under introduction of benralizumab for her severe asthma. However, 8 weeks later, symptoms and bilateral patchy infiltrates on chest radiography appeared. Lymphocytosis without eosinophilia was seen in bronchoalveolar lavage fluids, and transbronchial biopsy indicated organizing pneumonia. Cryptogenic organizing pneumonia (COP) was diagnosed and resolved with prednisolone at 30 mg/day. Prednisolone was tapered to 3 mg/day without relapse of CEP or COP. This case suggests the overlap and similar pathogenesis of CEP and COP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
---|---|
Enthalten in: |
Respiratory investigation - 62(2024), 2 vom: 15. Feb., Seite 231-233 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Morikawa, Keisuke [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.resinv.2023.12.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367151901 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367151901 | ||
003 | DE-627 | ||
005 | 20240229154910.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240116s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.resinv.2023.12.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM367151901 | ||
035 | |a (NLM)38224635 | ||
035 | |a (PII)S2212-5345(24)00003-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Morikawa, Keisuke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cryptogenic organizing pneumonia after withdrawal of systemic corticosteroids for chronic eosinophilic pneumonia and severe asthma under benralizumab treatment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. | ||
520 | |a A 79-year-old woman with severe asthma developed chronic eosinophilic pneumonia (CEP). After CEP resolved with oral prednisolone at 30 mg/day, prednisolone was tapered and discontinued under introduction of benralizumab for her severe asthma. However, 8 weeks later, symptoms and bilateral patchy infiltrates on chest radiography appeared. Lymphocytosis without eosinophilia was seen in bronchoalveolar lavage fluids, and transbronchial biopsy indicated organizing pneumonia. Cryptogenic organizing pneumonia (COP) was diagnosed and resolved with prednisolone at 30 mg/day. Prednisolone was tapered to 3 mg/day without relapse of CEP or COP. This case suggests the overlap and similar pathogenesis of CEP and COP | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Anti-Interleukin-5 antibody | |
650 | 4 | |a Anti-Interleukin-5 receptor α chain antibody | |
650 | 4 | |a Chronic eosinophilic pneumonia | |
650 | 4 | |a Cryptogenic organizing pneumonia | |
650 | 7 | |a benralizumab |2 NLM | |
650 | 7 | |a 71492GE1FX |2 NLM | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Prednisolone |2 NLM | |
650 | 7 | |a 9PHQ9Y1OLM |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
700 | 1 | |a Toyoshima, Mikio |e verfasserin |4 aut | |
700 | 1 | |a Koda, Keigo |e verfasserin |4 aut | |
700 | 1 | |a Kamiya, Yosuke |e verfasserin |4 aut | |
700 | 1 | |a Suda, Takafumi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiratory investigation |d 2012 |g 62(2024), 2 vom: 15. Feb., Seite 231-233 |w (DE-627)NLM217493343 |x 2212-5353 |7 nnns |
773 | 1 | 8 | |g volume:62 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:231-233 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.resinv.2023.12.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 62 |j 2024 |e 2 |b 15 |c 02 |h 231-233 |